nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoconazole—CYP2B6—Thiotepa—urinary bladder cancer	0.0765	0.151	CbGbCtD
Ketoconazole—ABCB1—Mitomycin—urinary bladder cancer	0.0517	0.102	CbGbCtD
Ketoconazole—CYP1B1—Doxorubicin—urinary bladder cancer	0.0423	0.0836	CbGbCtD
Ketoconazole—ABCB11—Doxorubicin—urinary bladder cancer	0.0423	0.0836	CbGbCtD
Ketoconazole—CYP2A6—Fluorouracil—urinary bladder cancer	0.0382	0.0755	CbGbCtD
Ketoconazole—SLCO1A2—Methotrexate—urinary bladder cancer	0.026	0.0514	CbGbCtD
Ketoconazole—CYP3A4—Thiotepa—urinary bladder cancer	0.0235	0.0465	CbGbCtD
Ketoconazole—CYP2B6—Cisplatin—urinary bladder cancer	0.0211	0.0417	CbGbCtD
Ketoconazole—CYP2C8—Fluorouracil—urinary bladder cancer	0.0188	0.0372	CbGbCtD
Ketoconazole—CYP3A5—Etoposide—urinary bladder cancer	0.0163	0.0323	CbGbCtD
Ketoconazole—CYP2C8—Etoposide—urinary bladder cancer	0.0157	0.0311	CbGbCtD
Ketoconazole—ABCB1—Gemcitabine—urinary bladder cancer	0.0149	0.0294	CbGbCtD
Ketoconazole—CYP1A2—Fluorouracil—urinary bladder cancer	0.0146	0.0288	CbGbCtD
Ketoconazole—CYP2B6—Doxorubicin—urinary bladder cancer	0.0141	0.028	CbGbCtD
Ketoconazole—CYP2C9—Fluorouracil—urinary bladder cancer	0.0131	0.026	CbGbCtD
Ketoconazole—CYP1A2—Etoposide—urinary bladder cancer	0.0122	0.024	CbGbCtD
Ketoconazole—CYP2C9—Cisplatin—urinary bladder cancer	0.0111	0.022	CbGbCtD
Ketoconazole—AR—scrotum—urinary bladder cancer	0.0111	0.114	CbGeAlD
Ketoconazole—ABCB1—Cisplatin—urinary bladder cancer	0.0108	0.0214	CbGbCtD
Ketoconazole—ABCB1—Etoposide—urinary bladder cancer	0.0106	0.021	CbGbCtD
Ketoconazole—ABCB1—Doxorubicin—urinary bladder cancer	0.00725	0.0143	CbGbCtD
Ketoconazole—ABCB1—Methotrexate—urinary bladder cancer	0.00702	0.0139	CbGbCtD
Ketoconazole—CYP2D6—Doxorubicin—urinary bladder cancer	0.00683	0.0135	CbGbCtD
Ketoconazole—CYP3A4—Etoposide—urinary bladder cancer	0.00637	0.0126	CbGbCtD
Ketoconazole—AR—penis—urinary bladder cancer	0.00499	0.0513	CbGeAlD
Ketoconazole—CYP3A4—Doxorubicin—urinary bladder cancer	0.00434	0.00859	CbGbCtD
Ketoconazole—CYP51A1—prostate gland—urinary bladder cancer	0.00372	0.0382	CbGeAlD
Ketoconazole—CYP24A1—prostate gland—urinary bladder cancer	0.00355	0.0364	CbGeAlD
Ketoconazole—CYP27B1—renal system—urinary bladder cancer	0.00349	0.0358	CbGeAlD
Ketoconazole—CYP26A1—female reproductive system—urinary bladder cancer	0.00313	0.0322	CbGeAlD
Ketoconazole—CYP2C19—urine—urinary bladder cancer	0.00308	0.0316	CbGeAlD
Ketoconazole—CYP24A1—seminal vesicle—urinary bladder cancer	0.003	0.0308	CbGeAlD
Ketoconazole—CYP27B1—female reproductive system—urinary bladder cancer	0.00279	0.0287	CbGeAlD
Ketoconazole—CYP27B1—vagina—urinary bladder cancer	0.00253	0.026	CbGeAlD
Ketoconazole—CYP1A2—urine—urinary bladder cancer	0.00251	0.0258	CbGeAlD
Ketoconazole—CYP11B2—renal system—urinary bladder cancer	0.00249	0.0255	CbGeAlD
Ketoconazole—CYP24A1—renal system—urinary bladder cancer	0.00242	0.0248	CbGeAlD
Ketoconazole—CYP2C9—urine—urinary bladder cancer	0.00239	0.0245	CbGeAlD
Ketoconazole—CYP24A1—female reproductive system—urinary bladder cancer	0.00194	0.0199	CbGeAlD
Ketoconazole—CYP3A4—urine—urinary bladder cancer	0.00182	0.0187	CbGeAlD
Ketoconazole—CYP2D6—urine—urinary bladder cancer	0.00179	0.0184	CbGeAlD
Ketoconazole—CYP24A1—vagina—urinary bladder cancer	0.00175	0.018	CbGeAlD
Ketoconazole—CYP2A6—prostate gland—urinary bladder cancer	0.00172	0.0176	CbGeAlD
Ketoconazole—CYP17A1—renal system—urinary bladder cancer	0.00152	0.0156	CbGeAlD
Ketoconazole—CYP2A6—seminal vesicle—urinary bladder cancer	0.00145	0.0149	CbGeAlD
Ketoconazole—CYP19A1—prostate gland—urinary bladder cancer	0.00135	0.0138	CbGeAlD
Ketoconazole—CYP1B1—prostate gland—urinary bladder cancer	0.00126	0.0129	CbGeAlD
Ketoconazole—CYP17A1—female reproductive system—urinary bladder cancer	0.00122	0.0125	CbGeAlD
Ketoconazole—AR—prostate gland—urinary bladder cancer	0.00119	0.0122	CbGeAlD
Ketoconazole—CYP11B2—lymph node—urinary bladder cancer	0.00116	0.012	CbGeAlD
Ketoconazole—CYP11A1—female reproductive system—urinary bladder cancer	0.00113	0.0116	CbGeAlD
Ketoconazole—AR—seminal vesicle—urinary bladder cancer	0.00101	0.0104	CbGeAlD
Ketoconazole—SLCO1A2—renal system—urinary bladder cancer	0.000941	0.00966	CbGeAlD
Ketoconazole—CYP1B1—smooth muscle tissue—urinary bladder cancer	0.000891	0.00916	CbGeAlD
Ketoconazole—AR—epithelium—urinary bladder cancer	0.000876	0.009	CbGeAlD
Ketoconazole—CYP3A5—prostate gland—urinary bladder cancer	0.00087	0.00894	CbGeAlD
Ketoconazole—CYP1B1—renal system—urinary bladder cancer	0.000858	0.00882	CbGeAlD
Ketoconazole—CYP2A6—vagina—urinary bladder cancer	0.000848	0.00871	CbGeAlD
Ketoconazole—AR—smooth muscle tissue—urinary bladder cancer	0.000844	0.00867	CbGeAlD
Ketoconazole—AR—renal system—urinary bladder cancer	0.000813	0.00835	CbGeAlD
Ketoconazole—AR—urethra—urinary bladder cancer	0.000798	0.0082	CbGeAlD
Ketoconazole—CYP19A1—female reproductive system—urinary bladder cancer	0.000735	0.00755	CbGeAlD
Ketoconazole—CYP17A1—lymph node—urinary bladder cancer	0.000711	0.00731	CbGeAlD
Ketoconazole—CYP1B1—female reproductive system—urinary bladder cancer	0.000687	0.00706	CbGeAlD
Ketoconazole—CYP11A1—lymph node—urinary bladder cancer	0.000662	0.0068	CbGeAlD
Ketoconazole—CYP2C8—renal system—urinary bladder cancer	0.000657	0.00675	CbGeAlD
Ketoconazole—CYP1A1—epithelium—urinary bladder cancer	0.000654	0.00672	CbGeAlD
Ketoconazole—AR—female reproductive system—urinary bladder cancer	0.000651	0.00669	CbGeAlD
Ketoconazole—CYP1A2—renal system—urinary bladder cancer	0.000615	0.00632	CbGeAlD
Ketoconazole—CYP1A1—renal system—urinary bladder cancer	0.000607	0.00623	CbGeAlD
Ketoconazole—CYP1A1—urethra—urinary bladder cancer	0.000596	0.00612	CbGeAlD
Ketoconazole—CYP3A5—renal system—urinary bladder cancer	0.000593	0.00609	CbGeAlD
Ketoconazole—CYP2B6—renal system—urinary bladder cancer	0.000589	0.00606	CbGeAlD
Ketoconazole—AR—vagina—urinary bladder cancer	0.000589	0.00605	CbGeAlD
Ketoconazole—CYP2C19—vagina—urinary bladder cancer	0.000545	0.0056	CbGeAlD
Ketoconazole—CYP2C8—female reproductive system—urinary bladder cancer	0.000526	0.00541	CbGeAlD
Ketoconazole—CYP1A1—female reproductive system—urinary bladder cancer	0.000486	0.00499	CbGeAlD
Ketoconazole—CYP2C8—vagina—urinary bladder cancer	0.000476	0.00489	CbGeAlD
Ketoconazole—CYP2B6—female reproductive system—urinary bladder cancer	0.000472	0.00485	CbGeAlD
Ketoconazole—CYP2C9—female reproductive system—urinary bladder cancer	0.000467	0.0048	CbGeAlD
Ketoconazole—ABCB1—prostate gland—urinary bladder cancer	0.000462	0.00475	CbGeAlD
Ketoconazole—CYP3A4—renal system—urinary bladder cancer	0.000445	0.00457	CbGeAlD
Ketoconazole—CYP1A1—vagina—urinary bladder cancer	0.000439	0.00451	CbGeAlD
Ketoconazole—CYP2D6—renal system—urinary bladder cancer	0.000438	0.0045	CbGeAlD
Ketoconazole—CYP19A1—lymph node—urinary bladder cancer	0.00043	0.00442	CbGeAlD
Ketoconazole—CYP3A5—vagina—urinary bladder cancer	0.00043	0.00441	CbGeAlD
Ketoconazole—CYP2B6—vagina—urinary bladder cancer	0.000427	0.00439	CbGeAlD
Ketoconazole—CYP1B1—lymph node—urinary bladder cancer	0.000402	0.00413	CbGeAlD
Ketoconazole—ABCB1—seminal vesicle—urinary bladder cancer	0.000391	0.00402	CbGeAlD
Ketoconazole—AR—lymph node—urinary bladder cancer	0.000381	0.00391	CbGeAlD
Ketoconazole—CYP3A4—female reproductive system—urinary bladder cancer	0.000356	0.00366	CbGeAlD
Ketoconazole—CYP2D6—female reproductive system—urinary bladder cancer	0.000351	0.0036	CbGeAlD
Ketoconazole—ABCB1—epithelium—urinary bladder cancer	0.00034	0.00349	CbGeAlD
Ketoconazole—ABCB1—renal system—urinary bladder cancer	0.000315	0.00324	CbGeAlD
Ketoconazole—ABCB1—urethra—urinary bladder cancer	0.00031	0.00318	CbGeAlD
Ketoconazole—CYP1A1—lymph node—urinary bladder cancer	0.000284	0.00292	CbGeAlD
Ketoconazole—ABCB1—female reproductive system—urinary bladder cancer	0.000252	0.00259	CbGeAlD
Ketoconazole—ABCB1—vagina—urinary bladder cancer	0.000228	0.00234	CbGeAlD
Ketoconazole—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000217	0.00123	CcSEcCtD
Ketoconazole—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000217	0.00123	CcSEcCtD
Ketoconazole—Asthenia—Thiotepa—urinary bladder cancer	0.000217	0.00123	CcSEcCtD
Ketoconazole—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000216	0.00122	CcSEcCtD
Ketoconazole—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000216	0.00122	CcSEcCtD
Ketoconazole—Pruritus—Thiotepa—urinary bladder cancer	0.000214	0.00121	CcSEcCtD
Ketoconazole—Pain—Fluorouracil—urinary bladder cancer	0.000214	0.00121	CcSEcCtD
Ketoconazole—Paraesthesia—Cisplatin—urinary bladder cancer	0.000213	0.0012	CcSEcCtD
Ketoconazole—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000212	0.0012	CcSEcCtD
Ketoconazole—Skin disorder—Etoposide—urinary bladder cancer	0.000211	0.00119	CcSEcCtD
Ketoconazole—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.00021	0.00119	CcSEcCtD
Ketoconazole—Dry skin—Doxorubicin—urinary bladder cancer	0.00021	0.00119	CcSEcCtD
Ketoconazole—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000209	0.00119	CcSEcCtD
Ketoconazole—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.000209	0.00118	CcSEcCtD
Ketoconazole—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.000209	0.00118	CcSEcCtD
Ketoconazole—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.000209	0.00118	CcSEcCtD
Ketoconazole—Breast disorder—Doxorubicin—urinary bladder cancer	0.000207	0.00117	CcSEcCtD
Ketoconazole—Anorexia—Etoposide—urinary bladder cancer	0.000207	0.00117	CcSEcCtD
Ketoconazole—Diarrhoea—Thiotepa—urinary bladder cancer	0.000207	0.00117	CcSEcCtD
Ketoconazole—Decreased appetite—Cisplatin—urinary bladder cancer	0.000206	0.00117	CcSEcCtD
Ketoconazole—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000206	0.00117	CcSEcCtD
Ketoconazole—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000204	0.00116	CcSEcCtD
Ketoconazole—Pain—Cisplatin—urinary bladder cancer	0.000202	0.00115	CcSEcCtD
Ketoconazole—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000201	0.00114	CcSEcCtD
Ketoconazole—Dizziness—Thiotepa—urinary bladder cancer	0.0002	0.00113	CcSEcCtD
Ketoconazole—Urticaria—Fluorouracil—urinary bladder cancer	0.000198	0.00112	CcSEcCtD
Ketoconazole—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000197	0.00112	CcSEcCtD
Ketoconazole—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000195	0.00111	CcSEcCtD
Ketoconazole—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000195	0.00111	CcSEcCtD
Ketoconazole—Paraesthesia—Etoposide—urinary bladder cancer	0.000195	0.0011	CcSEcCtD
Ketoconazole—Somnolence—Etoposide—urinary bladder cancer	0.000193	0.00109	CcSEcCtD
Ketoconazole—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000193	0.00109	CcSEcCtD
Ketoconazole—Epistaxis—Methotrexate—urinary bladder cancer	0.000192	0.00109	CcSEcCtD
Ketoconazole—Vomiting—Thiotepa—urinary bladder cancer	0.000192	0.00109	CcSEcCtD
Ketoconazole—Rash—Thiotepa—urinary bladder cancer	0.00019	0.00108	CcSEcCtD
Ketoconazole—Dermatitis—Thiotepa—urinary bladder cancer	0.00019	0.00108	CcSEcCtD
Ketoconazole—Headache—Thiotepa—urinary bladder cancer	0.000189	0.00107	CcSEcCtD
Ketoconazole—Decreased appetite—Etoposide—urinary bladder cancer	0.000189	0.00107	CcSEcCtD
Ketoconazole—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000187	0.00106	CcSEcCtD
Ketoconazole—Body temperature increased—Cisplatin—urinary bladder cancer	0.000187	0.00106	CcSEcCtD
Ketoconazole—Fatigue—Etoposide—urinary bladder cancer	0.000187	0.00106	CcSEcCtD
Ketoconazole—Jaundice—Epirubicin—urinary bladder cancer	0.000186	0.00105	CcSEcCtD
Ketoconazole—Pain—Etoposide—urinary bladder cancer	0.000186	0.00105	CcSEcCtD
Ketoconazole—Constipation—Etoposide—urinary bladder cancer	0.000186	0.00105	CcSEcCtD
Ketoconazole—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000184	0.00104	CcSEcCtD
Ketoconazole—Hepatitis—Methotrexate—urinary bladder cancer	0.000183	0.00104	CcSEcCtD
Ketoconazole—Asthenia—Gemcitabine—urinary bladder cancer	0.000182	0.00103	CcSEcCtD
Ketoconazole—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000181	0.00102	CcSEcCtD
Ketoconazole—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.00018	0.00102	CcSEcCtD
Ketoconazole—Epistaxis—Epirubicin—urinary bladder cancer	0.00018	0.00102	CcSEcCtD
Ketoconazole—Pruritus—Gemcitabine—urinary bladder cancer	0.00018	0.00102	CcSEcCtD
Ketoconazole—Nausea—Thiotepa—urinary bladder cancer	0.000179	0.00102	CcSEcCtD
Ketoconazole—Feeling abnormal—Etoposide—urinary bladder cancer	0.000179	0.00101	CcSEcCtD
Ketoconazole—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000177	0.001	CcSEcCtD
Ketoconazole—Pruritus—Fluorouracil—urinary bladder cancer	0.000177	0.001	CcSEcCtD
Ketoconazole—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000174	0.000988	CcSEcCtD
Ketoconazole—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000174	0.000985	CcSEcCtD
Ketoconazole—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000173	0.000979	CcSEcCtD
Ketoconazole—Urticaria—Etoposide—urinary bladder cancer	0.000172	0.000976	CcSEcCtD
Ketoconazole—Jaundice—Doxorubicin—urinary bladder cancer	0.000172	0.000974	CcSEcCtD
Ketoconazole—Abdominal pain—Etoposide—urinary bladder cancer	0.000171	0.000971	CcSEcCtD
Ketoconazole—Body temperature increased—Etoposide—urinary bladder cancer	0.000171	0.000971	CcSEcCtD
Ketoconazole—Hepatitis—Epirubicin—urinary bladder cancer	0.000171	0.000969	CcSEcCtD
Ketoconazole—Eye disorder—Methotrexate—urinary bladder cancer	0.000171	0.000968	CcSEcCtD
Ketoconazole—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000171	0.000968	CcSEcCtD
Ketoconazole—Asthenia—Cisplatin—urinary bladder cancer	0.00017	0.000962	CcSEcCtD
Ketoconazole—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000169	0.000955	CcSEcCtD
Ketoconazole—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000168	0.000953	CcSEcCtD
Ketoconazole—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000167	0.000945	CcSEcCtD
Ketoconazole—Epistaxis—Doxorubicin—urinary bladder cancer	0.000166	0.000942	CcSEcCtD
Ketoconazole—Angiopathy—Methotrexate—urinary bladder cancer	0.000166	0.00094	CcSEcCtD
Ketoconazole—Immune system disorder—Methotrexate—urinary bladder cancer	0.000165	0.000936	CcSEcCtD
Ketoconazole—Dizziness—Fluorouracil—urinary bladder cancer	0.000165	0.000936	CcSEcCtD
Ketoconazole—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000165	0.000934	CcSEcCtD
Ketoconazole—Chills—Methotrexate—urinary bladder cancer	0.000164	0.00093	CcSEcCtD
Ketoconazole—Diarrhoea—Cisplatin—urinary bladder cancer	0.000162	0.000918	CcSEcCtD
Ketoconazole—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000162	0.000917	CcSEcCtD
Ketoconazole—Alopecia—Methotrexate—urinary bladder cancer	0.000162	0.000915	CcSEcCtD
Ketoconazole—Vomiting—Gemcitabine—urinary bladder cancer	0.000162	0.000915	CcSEcCtD
Ketoconazole—Mental disorder—Methotrexate—urinary bladder cancer	0.00016	0.000908	CcSEcCtD
Ketoconazole—Rash—Gemcitabine—urinary bladder cancer	0.00016	0.000907	CcSEcCtD
Ketoconazole—Dermatitis—Gemcitabine—urinary bladder cancer	0.00016	0.000906	CcSEcCtD
Ketoconazole—Eye disorder—Epirubicin—urinary bladder cancer	0.00016	0.000906	CcSEcCtD
Ketoconazole—Hypersensitivity—Etoposide—urinary bladder cancer	0.00016	0.000905	CcSEcCtD
Ketoconazole—Erythema—Methotrexate—urinary bladder cancer	0.000159	0.000902	CcSEcCtD
Ketoconazole—Malnutrition—Methotrexate—urinary bladder cancer	0.000159	0.000902	CcSEcCtD
Ketoconazole—Headache—Gemcitabine—urinary bladder cancer	0.000159	0.000901	CcSEcCtD
Ketoconazole—Vomiting—Fluorouracil—urinary bladder cancer	0.000159	0.0009	CcSEcCtD
Ketoconazole—Hepatitis—Doxorubicin—urinary bladder cancer	0.000158	0.000897	CcSEcCtD
Ketoconazole—Rash—Fluorouracil—urinary bladder cancer	0.000157	0.000892	CcSEcCtD
Ketoconazole—Dermatitis—Fluorouracil—urinary bladder cancer	0.000157	0.000891	CcSEcCtD
Ketoconazole—Headache—Fluorouracil—urinary bladder cancer	0.000156	0.000886	CcSEcCtD
Ketoconazole—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000156	0.000884	CcSEcCtD
Ketoconazole—Dysgeusia—Methotrexate—urinary bladder cancer	0.000156	0.000883	CcSEcCtD
Ketoconazole—Asthenia—Etoposide—urinary bladder cancer	0.000156	0.000882	CcSEcCtD
Ketoconazole—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000156	0.000881	CcSEcCtD
Ketoconazole—Angiopathy—Epirubicin—urinary bladder cancer	0.000155	0.00088	CcSEcCtD
Ketoconazole—Immune system disorder—Epirubicin—urinary bladder cancer	0.000155	0.000876	CcSEcCtD
Ketoconazole—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000154	0.000874	CcSEcCtD
Ketoconazole—Chills—Epirubicin—urinary bladder cancer	0.000154	0.00087	CcSEcCtD
Ketoconazole—Pruritus—Etoposide—urinary bladder cancer	0.000153	0.000869	CcSEcCtD
Ketoconazole—Arrhythmia—Epirubicin—urinary bladder cancer	0.000153	0.000866	CcSEcCtD
Ketoconazole—Alopecia—Epirubicin—urinary bladder cancer	0.000151	0.000857	CcSEcCtD
Ketoconazole—Nausea—Gemcitabine—urinary bladder cancer	0.000151	0.000855	CcSEcCtD
Ketoconazole—Vomiting—Cisplatin—urinary bladder cancer	0.000151	0.000853	CcSEcCtD
Ketoconazole—Mental disorder—Epirubicin—urinary bladder cancer	0.00015	0.000849	CcSEcCtD
Ketoconazole—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.00015	0.000848	CcSEcCtD
Ketoconazole—Rash—Cisplatin—urinary bladder cancer	0.000149	0.000846	CcSEcCtD
Ketoconazole—Dermatitis—Cisplatin—urinary bladder cancer	0.000149	0.000845	CcSEcCtD
Ketoconazole—Erythema—Epirubicin—urinary bladder cancer	0.000149	0.000844	CcSEcCtD
Ketoconazole—Malnutrition—Epirubicin—urinary bladder cancer	0.000149	0.000844	CcSEcCtD
Ketoconazole—Diarrhoea—Etoposide—urinary bladder cancer	0.000148	0.000841	CcSEcCtD
Ketoconazole—Nausea—Fluorouracil—urinary bladder cancer	0.000148	0.00084	CcSEcCtD
Ketoconazole—Eye disorder—Doxorubicin—urinary bladder cancer	0.000148	0.000838	CcSEcCtD
Ketoconazole—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000148	0.000837	CcSEcCtD
Ketoconazole—ABCB1—lymph node—urinary bladder cancer	0.000148	0.00152	CbGeAlD
Ketoconazole—Flatulence—Epirubicin—urinary bladder cancer	0.000147	0.000832	CcSEcCtD
Ketoconazole—Tension—Epirubicin—urinary bladder cancer	0.000146	0.000828	CcSEcCtD
Ketoconazole—Dysgeusia—Epirubicin—urinary bladder cancer	0.000146	0.000826	CcSEcCtD
Ketoconazole—Nervousness—Epirubicin—urinary bladder cancer	0.000145	0.00082	CcSEcCtD
Ketoconazole—Angiopathy—Doxorubicin—urinary bladder cancer	0.000144	0.000814	CcSEcCtD
Ketoconazole—Malaise—Methotrexate—urinary bladder cancer	0.000144	0.000813	CcSEcCtD
Ketoconazole—Dizziness—Etoposide—urinary bladder cancer	0.000143	0.000813	CcSEcCtD
Ketoconazole—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000143	0.00081	CcSEcCtD
Ketoconazole—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000143	0.000808	CcSEcCtD
Ketoconazole—Leukopenia—Methotrexate—urinary bladder cancer	0.000143	0.000807	CcSEcCtD
Ketoconazole—Chills—Doxorubicin—urinary bladder cancer	0.000142	0.000805	CcSEcCtD
Ketoconazole—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000141	0.000801	CcSEcCtD
Ketoconazole—Nausea—Cisplatin—urinary bladder cancer	0.000141	0.000797	CcSEcCtD
Ketoconazole—Alopecia—Doxorubicin—urinary bladder cancer	0.00014	0.000793	CcSEcCtD
Ketoconazole—Mental disorder—Doxorubicin—urinary bladder cancer	0.000139	0.000786	CcSEcCtD
Ketoconazole—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000138	0.000783	CcSEcCtD
Ketoconazole—Vomiting—Etoposide—urinary bladder cancer	0.000138	0.000781	CcSEcCtD
Ketoconazole—Malnutrition—Doxorubicin—urinary bladder cancer	0.000138	0.000781	CcSEcCtD
Ketoconazole—Erythema—Doxorubicin—urinary bladder cancer	0.000138	0.000781	CcSEcCtD
Ketoconazole—Rash—Etoposide—urinary bladder cancer	0.000137	0.000775	CcSEcCtD
Ketoconazole—Dermatitis—Etoposide—urinary bladder cancer	0.000137	0.000774	CcSEcCtD
Ketoconazole—Headache—Etoposide—urinary bladder cancer	0.000136	0.00077	CcSEcCtD
Ketoconazole—Flatulence—Doxorubicin—urinary bladder cancer	0.000136	0.000769	CcSEcCtD
Ketoconazole—Myalgia—Methotrexate—urinary bladder cancer	0.000136	0.000768	CcSEcCtD
Ketoconazole—Arthralgia—Methotrexate—urinary bladder cancer	0.000136	0.000768	CcSEcCtD
Ketoconazole—Tension—Doxorubicin—urinary bladder cancer	0.000135	0.000766	CcSEcCtD
Ketoconazole—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000135	0.000765	CcSEcCtD
Ketoconazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000135	0.000762	CcSEcCtD
Ketoconazole—Malaise—Epirubicin—urinary bladder cancer	0.000134	0.000761	CcSEcCtD
Ketoconazole—Discomfort—Methotrexate—urinary bladder cancer	0.000134	0.000759	CcSEcCtD
Ketoconazole—Nervousness—Doxorubicin—urinary bladder cancer	0.000134	0.000758	CcSEcCtD
Ketoconazole—Leukopenia—Epirubicin—urinary bladder cancer	0.000133	0.000755	CcSEcCtD
Ketoconazole—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.00013	0.000736	CcSEcCtD
Ketoconazole—Nausea—Etoposide—urinary bladder cancer	0.000129	0.00073	CcSEcCtD
Ketoconazole—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000128	0.000725	CcSEcCtD
Ketoconazole—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000127	0.000722	CcSEcCtD
Ketoconazole—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000127	0.000721	CcSEcCtD
Ketoconazole—Arthralgia—Epirubicin—urinary bladder cancer	0.000127	0.000718	CcSEcCtD
Ketoconazole—Myalgia—Epirubicin—urinary bladder cancer	0.000127	0.000718	CcSEcCtD
Ketoconazole—Skin disorder—Methotrexate—urinary bladder cancer	0.000126	0.000715	CcSEcCtD
Ketoconazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000126	0.000714	CcSEcCtD
Ketoconazole—Discomfort—Epirubicin—urinary bladder cancer	0.000125	0.00071	CcSEcCtD
Ketoconazole—Malaise—Doxorubicin—urinary bladder cancer	0.000124	0.000704	CcSEcCtD
Ketoconazole—Dry mouth—Epirubicin—urinary bladder cancer	0.000124	0.000703	CcSEcCtD
Ketoconazole—Anorexia—Methotrexate—urinary bladder cancer	0.000124	0.000702	CcSEcCtD
Ketoconazole—Leukopenia—Doxorubicin—urinary bladder cancer	0.000123	0.000699	CcSEcCtD
Ketoconazole—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000122	0.000689	CcSEcCtD
Ketoconazole—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000119	0.000675	CcSEcCtD
Ketoconazole—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000119	0.000674	CcSEcCtD
Ketoconazole—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000118	0.000671	CcSEcCtD
Ketoconazole—Skin disorder—Epirubicin—urinary bladder cancer	0.000118	0.000669	CcSEcCtD
Ketoconazole—Insomnia—Methotrexate—urinary bladder cancer	0.000118	0.000666	CcSEcCtD
Ketoconazole—Myalgia—Doxorubicin—urinary bladder cancer	0.000117	0.000665	CcSEcCtD
Ketoconazole—Arthralgia—Doxorubicin—urinary bladder cancer	0.000117	0.000665	CcSEcCtD
Ketoconazole—Paraesthesia—Methotrexate—urinary bladder cancer	0.000117	0.000661	CcSEcCtD
Ketoconazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000117	0.00066	CcSEcCtD
Ketoconazole—Discomfort—Doxorubicin—urinary bladder cancer	0.000116	0.000657	CcSEcCtD
Ketoconazole—Anorexia—Epirubicin—urinary bladder cancer	0.000116	0.000657	CcSEcCtD
Ketoconazole—Somnolence—Methotrexate—urinary bladder cancer	0.000116	0.000654	CcSEcCtD
Ketoconazole—Dry mouth—Doxorubicin—urinary bladder cancer	0.000115	0.00065	CcSEcCtD
Ketoconazole—Dyspepsia—Methotrexate—urinary bladder cancer	0.000114	0.000648	CcSEcCtD
Ketoconazole—Decreased appetite—Methotrexate—urinary bladder cancer	0.000113	0.00064	CcSEcCtD
Ketoconazole—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000113	0.000637	CcSEcCtD
Ketoconazole—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000112	0.000635	CcSEcCtD
Ketoconazole—Fatigue—Methotrexate—urinary bladder cancer	0.000112	0.000635	CcSEcCtD
Ketoconazole—Pain—Methotrexate—urinary bladder cancer	0.000111	0.000629	CcSEcCtD
Ketoconazole—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000111	0.000628	CcSEcCtD
Ketoconazole—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.00011	0.000625	CcSEcCtD
Ketoconazole—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.00011	0.000624	CcSEcCtD
Ketoconazole—Insomnia—Epirubicin—urinary bladder cancer	0.00011	0.000623	CcSEcCtD
Ketoconazole—Skin disorder—Doxorubicin—urinary bladder cancer	0.000109	0.000619	CcSEcCtD
Ketoconazole—Paraesthesia—Epirubicin—urinary bladder cancer	0.000109	0.000618	CcSEcCtD
Ketoconazole—Somnolence—Epirubicin—urinary bladder cancer	0.000108	0.000612	CcSEcCtD
Ketoconazole—Anorexia—Doxorubicin—urinary bladder cancer	0.000107	0.000607	CcSEcCtD
Ketoconazole—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000107	0.000607	CcSEcCtD
Ketoconazole—Dyspepsia—Epirubicin—urinary bladder cancer	0.000107	0.000606	CcSEcCtD
Ketoconazole—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000106	0.000602	CcSEcCtD
Ketoconazole—Decreased appetite—Epirubicin—urinary bladder cancer	0.000106	0.000599	CcSEcCtD
Ketoconazole—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000105	0.000595	CcSEcCtD
Ketoconazole—Fatigue—Epirubicin—urinary bladder cancer	0.000105	0.000594	CcSEcCtD
Ketoconazole—Pain—Epirubicin—urinary bladder cancer	0.000104	0.000589	CcSEcCtD
Ketoconazole—Constipation—Epirubicin—urinary bladder cancer	0.000104	0.000589	CcSEcCtD
Ketoconazole—Urticaria—Methotrexate—urinary bladder cancer	0.000103	0.000585	CcSEcCtD
Ketoconazole—Abdominal pain—Methotrexate—urinary bladder cancer	0.000103	0.000582	CcSEcCtD
Ketoconazole—Body temperature increased—Methotrexate—urinary bladder cancer	0.000103	0.000582	CcSEcCtD
Ketoconazole—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000103	0.000581	CcSEcCtD
Ketoconazole—Insomnia—Doxorubicin—urinary bladder cancer	0.000102	0.000576	CcSEcCtD
Ketoconazole—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000101	0.000572	CcSEcCtD
Ketoconazole—Feeling abnormal—Epirubicin—urinary bladder cancer	0.0001	0.000568	CcSEcCtD
Ketoconazole—Somnolence—Doxorubicin—urinary bladder cancer	0.0001	0.000567	CcSEcCtD
Ketoconazole—Gastrointestinal pain—Epirubicin—urinary bladder cancer	9.94e-05	0.000563	CcSEcCtD
Ketoconazole—Dyspepsia—Doxorubicin—urinary bladder cancer	9.9e-05	0.000561	CcSEcCtD
Ketoconazole—Decreased appetite—Doxorubicin—urinary bladder cancer	9.78e-05	0.000554	CcSEcCtD
Ketoconazole—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	9.71e-05	0.00055	CcSEcCtD
Ketoconazole—Fatigue—Doxorubicin—urinary bladder cancer	9.7e-05	0.000549	CcSEcCtD
Ketoconazole—Urticaria—Epirubicin—urinary bladder cancer	9.66e-05	0.000547	CcSEcCtD
Ketoconazole—Constipation—Doxorubicin—urinary bladder cancer	9.62e-05	0.000545	CcSEcCtD
Ketoconazole—Pain—Doxorubicin—urinary bladder cancer	9.62e-05	0.000545	CcSEcCtD
Ketoconazole—Body temperature increased—Epirubicin—urinary bladder cancer	9.61e-05	0.000544	CcSEcCtD
Ketoconazole—Abdominal pain—Epirubicin—urinary bladder cancer	9.61e-05	0.000544	CcSEcCtD
Ketoconazole—Hypersensitivity—Methotrexate—urinary bladder cancer	9.57e-05	0.000542	CcSEcCtD
Ketoconazole—Asthenia—Methotrexate—urinary bladder cancer	9.32e-05	0.000528	CcSEcCtD
Ketoconazole—Feeling abnormal—Doxorubicin—urinary bladder cancer	9.27e-05	0.000525	CcSEcCtD
Ketoconazole—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	9.2e-05	0.000521	CcSEcCtD
Ketoconazole—Pruritus—Methotrexate—urinary bladder cancer	9.19e-05	0.000521	CcSEcCtD
Ketoconazole—Hypersensitivity—Epirubicin—urinary bladder cancer	8.96e-05	0.000507	CcSEcCtD
Ketoconazole—Urticaria—Doxorubicin—urinary bladder cancer	8.94e-05	0.000506	CcSEcCtD
Ketoconazole—Abdominal pain—Doxorubicin—urinary bladder cancer	8.89e-05	0.000504	CcSEcCtD
Ketoconazole—Body temperature increased—Doxorubicin—urinary bladder cancer	8.89e-05	0.000504	CcSEcCtD
Ketoconazole—Diarrhoea—Methotrexate—urinary bladder cancer	8.89e-05	0.000504	CcSEcCtD
Ketoconazole—Asthenia—Epirubicin—urinary bladder cancer	8.72e-05	0.000494	CcSEcCtD
Ketoconazole—Pruritus—Epirubicin—urinary bladder cancer	8.6e-05	0.000487	CcSEcCtD
Ketoconazole—Dizziness—Methotrexate—urinary bladder cancer	8.59e-05	0.000487	CcSEcCtD
Ketoconazole—Diarrhoea—Epirubicin—urinary bladder cancer	8.32e-05	0.000471	CcSEcCtD
Ketoconazole—Hypersensitivity—Doxorubicin—urinary bladder cancer	8.29e-05	0.00047	CcSEcCtD
Ketoconazole—Vomiting—Methotrexate—urinary bladder cancer	8.26e-05	0.000468	CcSEcCtD
Ketoconazole—Rash—Methotrexate—urinary bladder cancer	8.19e-05	0.000464	CcSEcCtD
Ketoconazole—Dermatitis—Methotrexate—urinary bladder cancer	8.19e-05	0.000464	CcSEcCtD
Ketoconazole—Headache—Methotrexate—urinary bladder cancer	8.14e-05	0.000461	CcSEcCtD
Ketoconazole—Asthenia—Doxorubicin—urinary bladder cancer	8.07e-05	0.000457	CcSEcCtD
Ketoconazole—Dizziness—Epirubicin—urinary bladder cancer	8.04e-05	0.000455	CcSEcCtD
Ketoconazole—Pruritus—Doxorubicin—urinary bladder cancer	7.96e-05	0.000451	CcSEcCtD
Ketoconazole—Vomiting—Epirubicin—urinary bladder cancer	7.73e-05	0.000438	CcSEcCtD
Ketoconazole—Nausea—Methotrexate—urinary bladder cancer	7.72e-05	0.000437	CcSEcCtD
Ketoconazole—Diarrhoea—Doxorubicin—urinary bladder cancer	7.7e-05	0.000436	CcSEcCtD
Ketoconazole—Rash—Epirubicin—urinary bladder cancer	7.67e-05	0.000434	CcSEcCtD
Ketoconazole—Dermatitis—Epirubicin—urinary bladder cancer	7.66e-05	0.000434	CcSEcCtD
Ketoconazole—Headache—Epirubicin—urinary bladder cancer	7.62e-05	0.000431	CcSEcCtD
Ketoconazole—Dizziness—Doxorubicin—urinary bladder cancer	7.44e-05	0.000421	CcSEcCtD
Ketoconazole—Nausea—Epirubicin—urinary bladder cancer	7.22e-05	0.000409	CcSEcCtD
Ketoconazole—Vomiting—Doxorubicin—urinary bladder cancer	7.15e-05	0.000405	CcSEcCtD
Ketoconazole—Rash—Doxorubicin—urinary bladder cancer	7.09e-05	0.000402	CcSEcCtD
Ketoconazole—Dermatitis—Doxorubicin—urinary bladder cancer	7.09e-05	0.000401	CcSEcCtD
Ketoconazole—Headache—Doxorubicin—urinary bladder cancer	7.05e-05	0.000399	CcSEcCtD
Ketoconazole—Nausea—Doxorubicin—urinary bladder cancer	6.68e-05	0.000379	CcSEcCtD
Ketoconazole—CYP17A1—Metabolism—PTGS2—urinary bladder cancer	1.01e-05	4.58e-05	CbGpPWpGaD
Ketoconazole—CYP1B1—Metabolism—GPX1—urinary bladder cancer	1e-05	4.54e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	9.96e-06	4.52e-05	CbGpPWpGaD
Ketoconazole—ABCB11—Metabolism—CREBBP—urinary bladder cancer	9.91e-06	4.5e-05	CbGpPWpGaD
Ketoconazole—CYP51A1—Metabolism—EP300—urinary bladder cancer	9.89e-06	4.48e-05	CbGpPWpGaD
Ketoconazole—CYP1B1—Metabolism—ERCC2—urinary bladder cancer	9.84e-06	4.46e-05	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—NAT2—urinary bladder cancer	9.82e-06	4.45e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—NAT2—urinary bladder cancer	9.73e-06	4.41e-05	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	9.65e-06	4.38e-05	CbGpPWpGaD
Ketoconazole—CYP19A1—Metabolism—MTHFR—urinary bladder cancer	9.6e-06	4.35e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	9.56e-06	4.34e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism—ENO2—urinary bladder cancer	9.56e-06	4.34e-05	CbGpPWpGaD
Ketoconazole—CYP3A7—Metabolism—TYMS—urinary bladder cancer	9.54e-06	4.33e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	9.51e-06	4.31e-05	CbGpPWpGaD
Ketoconazole—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	9.43e-06	4.28e-05	CbGpPWpGaD
Ketoconazole—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	9.43e-06	4.28e-05	CbGpPWpGaD
Ketoconazole—CYP11B1—Metabolism—PTEN—urinary bladder cancer	9.43e-06	4.27e-05	CbGpPWpGaD
Ketoconazole—CYP2A6—Metabolism—GSTP1—urinary bladder cancer	9.41e-06	4.27e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	9.29e-06	4.21e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	9.27e-06	4.21e-05	CbGpPWpGaD
Ketoconazole—CYP11A1—Metabolism—PTGS2—urinary bladder cancer	9.25e-06	4.19e-05	CbGpPWpGaD
Ketoconazole—CYP1B1—Metabolism—MTHFR—urinary bladder cancer	9.25e-06	4.19e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	9.23e-06	4.18e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism—RRM2—urinary bladder cancer	9.22e-06	4.18e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—TYMP—urinary bladder cancer	9.2e-06	4.17e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	9.13e-06	4.14e-05	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	9.11e-06	4.13e-05	CbGpPWpGaD
Ketoconazole—CYP2B6—Metabolism—NQO1—urinary bladder cancer	9.1e-06	4.13e-05	CbGpPWpGaD
Ketoconazole—CYP3A7—Metabolism—GPX1—urinary bladder cancer	9.04e-06	4.1e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Metabolism—RRM2—urinary bladder cancer	8.99e-06	4.08e-05	CbGpPWpGaD
Ketoconazole—CYP11B1—Metabolism—EP300—urinary bladder cancer	8.99e-06	4.08e-05	CbGpPWpGaD
Ketoconazole—CYP3A5—Metabolism—NQO1—urinary bladder cancer	8.9e-06	4.03e-05	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	8.88e-06	4.03e-05	CbGpPWpGaD
Ketoconazole—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	8.87e-06	4.02e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	8.83e-06	4.01e-05	CbGpPWpGaD
Ketoconazole—CYP17A1—Metabolism—PTEN—urinary bladder cancer	8.82e-06	4e-05	CbGpPWpGaD
Ketoconazole—CYP2A6—Metabolism—TYMS—urinary bladder cancer	8.75e-06	3.97e-05	CbGpPWpGaD
Ketoconazole—CYP2A6—Metabolism—GSTM1—urinary bladder cancer	8.65e-06	3.92e-05	CbGpPWpGaD
Ketoconazole—CYP2A6—Metabolism—NCOR1—urinary bladder cancer	8.65e-06	3.92e-05	CbGpPWpGaD
Ketoconazole—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	8.62e-06	3.91e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	8.53e-06	3.87e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism—ENO2—urinary bladder cancer	8.53e-06	3.87e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	8.48e-06	3.85e-05	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—RRM2—urinary bladder cancer	8.48e-06	3.84e-05	CbGpPWpGaD
Ketoconazole—CYP17A1—Metabolism—EP300—urinary bladder cancer	8.41e-06	3.81e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism—NQO1—urinary bladder cancer	8.41e-06	3.81e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—RRM2—urinary bladder cancer	8.4e-06	3.81e-05	CbGpPWpGaD
Ketoconazole—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	8.34e-06	3.78e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Metabolism—ENO2—urinary bladder cancer	8.33e-06	3.78e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Metabolism—HPGDS—urinary bladder cancer	8.33e-06	3.78e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—NAT2—urinary bladder cancer	8.32e-06	3.77e-05	CbGpPWpGaD
Ketoconazole—CYP2A6—Metabolism—GPX1—urinary bladder cancer	8.28e-06	3.76e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	8.28e-06	3.75e-05	CbGpPWpGaD
Ketoconazole—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	8.28e-06	3.75e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	8.16e-06	3.7e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	8.15e-06	3.7e-05	CbGpPWpGaD
Ketoconazole—CYP2A6—Metabolism—ERCC2—urinary bladder cancer	8.13e-06	3.69e-05	CbGpPWpGaD
Ketoconazole—ABCB11—Metabolism—PTGS2—urinary bladder cancer	8.12e-06	3.68e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Metabolism—GSTT1—urinary bladder cancer	8.08e-06	3.66e-05	CbGpPWpGaD
Ketoconazole—CYP11A1—Metabolism—PTEN—urinary bladder cancer	8.06e-06	3.66e-05	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	7.85e-06	3.56e-05	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—ENO2—urinary bladder cancer	7.85e-06	3.56e-05	CbGpPWpGaD
Ketoconazole—CYP19A1—Metabolism—PPARG—urinary bladder cancer	7.79e-06	3.53e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	7.78e-06	3.53e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—ENO2—urinary bladder cancer	7.78e-06	3.53e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	7.74e-06	3.51e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism—NQO1—urinary bladder cancer	7.71e-06	3.49e-05	CbGpPWpGaD
Ketoconazole—CYP11A1—Metabolism—EP300—urinary bladder cancer	7.69e-06	3.49e-05	CbGpPWpGaD
Ketoconazole—CYP2A6—Metabolism—MTHFR—urinary bladder cancer	7.64e-06	3.47e-05	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	7.61e-06	3.45e-05	CbGpPWpGaD
Ketoconazole—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	7.59e-06	3.44e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	7.56e-06	3.43e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	7.55e-06	3.42e-05	CbGpPWpGaD
Ketoconazole—CYP1B1—Metabolism—PPARG—urinary bladder cancer	7.5e-06	3.4e-05	CbGpPWpGaD
Ketoconazole—CYP19A1—Metabolism—CREBBP—urinary bladder cancer	7.48e-06	3.39e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	7.48e-06	3.39e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	7.43e-06	3.37e-05	CbGpPWpGaD
Ketoconazole—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	7.42e-06	3.37e-05	CbGpPWpGaD
Ketoconazole—CYP1B1—Metabolism—CREBBP—urinary bladder cancer	7.2e-06	3.27e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—RRM2—urinary bladder cancer	7.18e-06	3.26e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.11e-06	3.23e-05	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—TYMP—urinary bladder cancer	7.1e-06	3.22e-05	CbGpPWpGaD
Ketoconazole—ABCB11—Metabolism—PTEN—urinary bladder cancer	7.08e-06	3.21e-05	CbGpPWpGaD
Ketoconazole—CYP2B6—Metabolism—TYMS—urinary bladder cancer	7.06e-06	3.2e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism—GSTP1—urinary bladder cancer	7.01e-06	3.18e-05	CbGpPWpGaD
Ketoconazole—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	6.98e-06	3.16e-05	CbGpPWpGaD
Ketoconazole—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	6.98e-06	3.16e-05	CbGpPWpGaD
Ketoconazole—CYP3A5—Metabolism—TYMS—urinary bladder cancer	6.9e-06	3.13e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism—NQO1—urinary bladder cancer	6.88e-06	3.12e-05	CbGpPWpGaD
Ketoconazole—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	6.82e-06	3.09e-05	CbGpPWpGaD
Ketoconazole—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	6.82e-06	3.09e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.78e-06	3.08e-05	CbGpPWpGaD
Ketoconazole—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	6.78e-06	3.07e-05	CbGpPWpGaD
Ketoconazole—CYP3A7—Metabolism—PPARG—urinary bladder cancer	6.76e-06	3.07e-05	CbGpPWpGaD
Ketoconazole—ABCB11—Metabolism—EP300—urinary bladder cancer	6.75e-06	3.06e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Metabolism—NQO1—urinary bladder cancer	6.71e-06	3.04e-05	CbGpPWpGaD
Ketoconazole—CYP2B6—Metabolism—GPX1—urinary bladder cancer	6.68e-06	3.03e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.67e-06	3.03e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	6.65e-06	3.02e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—ENO2—urinary bladder cancer	6.65e-06	3.02e-05	CbGpPWpGaD
Ketoconazole—AR—Gene Expression—MYC—urinary bladder cancer	6.63e-06	3.01e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	6.61e-06	3e-05	CbGpPWpGaD
Ketoconazole—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	6.56e-06	2.97e-05	CbGpPWpGaD
Ketoconazole—CYP3A5—Metabolism—GPX1—urinary bladder cancer	6.53e-06	2.96e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	6.52e-06	2.96e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism—TYMS—urinary bladder cancer	6.52e-06	2.96e-05	CbGpPWpGaD
Ketoconazole—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	6.5e-06	2.95e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	6.45e-06	2.92e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism—GSTM1—urinary bladder cancer	6.44e-06	2.92e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism—NCOR1—urinary bladder cancer	6.44e-06	2.92e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	6.43e-06	2.91e-05	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—NAT2—urinary bladder cancer	6.42e-06	2.91e-05	CbGpPWpGaD
Ketoconazole—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	6.41e-06	2.91e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	6.35e-06	2.88e-05	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—NQO1—urinary bladder cancer	6.33e-06	2.87e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—NQO1—urinary bladder cancer	6.27e-06	2.84e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.22e-06	2.82e-05	CbGpPWpGaD
Ketoconazole—CYP2A6—Metabolism—PPARG—urinary bladder cancer	6.2e-06	2.81e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism—GPX1—urinary bladder cancer	6.17e-06	2.8e-05	CbGpPWpGaD
Ketoconazole—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	6.17e-06	2.8e-05	CbGpPWpGaD
Ketoconazole—CYP19A1—Metabolism—PTGS2—urinary bladder cancer	6.13e-06	2.78e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.09e-06	2.76e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism—ERCC2—urinary bladder cancer	6.06e-06	2.75e-05	CbGpPWpGaD
Ketoconazole—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	6.03e-06	2.73e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism—TYMS—urinary bladder cancer	5.98e-06	2.71e-05	CbGpPWpGaD
Ketoconazole—CYP2A6—Metabolism—CREBBP—urinary bladder cancer	5.95e-06	2.7e-05	CbGpPWpGaD
Ketoconazole—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	5.91e-06	2.68e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	5.91e-06	2.68e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	5.91e-06	2.68e-05	CbGpPWpGaD
Ketoconazole—CYP1B1—Metabolism—PTGS2—urinary bladder cancer	5.9e-06	2.67e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.82e-06	2.64e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	5.74e-06	2.6e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism—MTHFR—urinary bladder cancer	5.69e-06	2.58e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism—GPX1—urinary bladder cancer	5.66e-06	2.57e-05	CbGpPWpGaD
Ketoconazole—SLCO1A2—Metabolism—EP300—urinary bladder cancer	5.64e-06	2.56e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Metabolism—GSTP1—urinary bladder cancer	5.6e-06	2.54e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	5.55e-06	2.52e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.55e-06	2.52e-05	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—RRM2—urinary bladder cancer	5.54e-06	2.51e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—NQO1—urinary bladder cancer	5.36e-06	2.43e-05	CbGpPWpGaD
Ketoconazole—CYP19A1—Metabolism—PTEN—urinary bladder cancer	5.34e-06	2.42e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism—TYMS—urinary bladder cancer	5.33e-06	2.42e-05	CbGpPWpGaD
Ketoconazole—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	5.32e-06	2.41e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.31e-06	2.41e-05	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	5.28e-06	2.39e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	5.27e-06	2.39e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	5.27e-06	2.39e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	5.23e-06	2.37e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	5.22e-06	2.37e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Metabolism—TYMS—urinary bladder cancer	5.21e-06	2.36e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	5.2e-06	2.36e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Metabolism—NCOR1—urinary bladder cancer	5.15e-06	2.33e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Metabolism—GSTM1—urinary bladder cancer	5.15e-06	2.33e-05	CbGpPWpGaD
Ketoconazole—CYP1B1—Metabolism—PTEN—urinary bladder cancer	5.14e-06	2.33e-05	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—ENO2—urinary bladder cancer	5.13e-06	2.33e-05	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	5.13e-06	2.33e-05	CbGpPWpGaD
Ketoconazole—CYP19A1—Metabolism—EP300—urinary bladder cancer	5.09e-06	2.31e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.06e-06	2.3e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism—GPX1—urinary bladder cancer	5.05e-06	2.29e-05	CbGpPWpGaD
Ketoconazole—CYP2B6—Metabolism—PPARG—urinary bladder cancer	5e-06	2.27e-05	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	4.98e-06	2.26e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	4.96e-06	2.25e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Metabolism—GPX1—urinary bladder cancer	4.93e-06	2.23e-05	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—TYMS—urinary bladder cancer	4.91e-06	2.22e-05	CbGpPWpGaD
Ketoconazole—CYP1B1—Metabolism—EP300—urinary bladder cancer	4.91e-06	2.22e-05	CbGpPWpGaD
Ketoconazole—CYP3A5—Metabolism—PPARG—urinary bladder cancer	4.89e-06	2.22e-05	CbGpPWpGaD
Ketoconazole—CYP2A6—Metabolism—PTGS2—urinary bladder cancer	4.88e-06	2.21e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—TYMS—urinary bladder cancer	4.86e-06	2.21e-05	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	4.85e-06	2.2e-05	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	4.85e-06	2.2e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Metabolism—ERCC2—urinary bladder cancer	4.84e-06	2.19e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	4.81e-06	2.18e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	4.81e-06	2.18e-05	CbGpPWpGaD
Ketoconazole—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	4.8e-06	2.18e-05	CbGpPWpGaD
Ketoconazole—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	4.7e-06	2.13e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	4.66e-06	2.11e-05	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—GPX1—urinary bladder cancer	4.64e-06	2.11e-05	CbGpPWpGaD
Ketoconazole—CYP3A7—Metabolism—PTEN—urinary bladder cancer	4.64e-06	2.1e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism—PPARG—urinary bladder cancer	4.62e-06	2.09e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—GPX1—urinary bladder cancer	4.6e-06	2.09e-05	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	4.56e-06	2.07e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Metabolism—MTHFR—urinary bladder cancer	4.55e-06	2.06e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.54e-06	2.06e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	4.52e-06	2.05e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	4.47e-06	2.03e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism—CREBBP—urinary bladder cancer	4.44e-06	2.01e-05	CbGpPWpGaD
Ketoconazole—CYP3A7—Metabolism—EP300—urinary bladder cancer	4.42e-06	2.01e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.33e-06	1.96e-05	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	4.29e-06	1.94e-05	CbGpPWpGaD
Ketoconazole—CYP2A6—Metabolism—PTEN—urinary bladder cancer	4.25e-06	1.93e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	4.25e-06	1.93e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism—PPARG—urinary bladder cancer	4.23e-06	1.92e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—TYMS—urinary bladder cancer	4.16e-06	1.88e-05	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—NQO1—urinary bladder cancer	4.14e-06	1.88e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	4.11e-06	1.86e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	4.11e-06	1.86e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	4.07e-06	1.84e-05	CbGpPWpGaD
Ketoconazole—CYP2A6—Metabolism—EP300—urinary bladder cancer	4.05e-06	1.84e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—GPX1—urinary bladder cancer	3.93e-06	1.78e-05	CbGpPWpGaD
Ketoconazole—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	3.93e-06	1.78e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	3.86e-06	1.75e-05	CbGpPWpGaD
Ketoconazole—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	3.84e-06	1.74e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism—PPARG—urinary bladder cancer	3.78e-06	1.71e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Metabolism—PPARG—urinary bladder cancer	3.69e-06	1.67e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism—PTGS2—urinary bladder cancer	3.63e-06	1.65e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	3.63e-06	1.65e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	3.63e-06	1.65e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Metabolism—CREBBP—urinary bladder cancer	3.54e-06	1.61e-05	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—PPARG—urinary bladder cancer	3.48e-06	1.58e-05	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	3.45e-06	1.56e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—PPARG—urinary bladder cancer	3.45e-06	1.56e-05	CbGpPWpGaD
Ketoconazole—CYP2B6—Metabolism—PTEN—urinary bladder cancer	3.43e-06	1.56e-05	CbGpPWpGaD
Ketoconazole—CYP3A5—Metabolism—PTEN—urinary bladder cancer	3.35e-06	1.52e-05	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	3.34e-06	1.51e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	3.33e-06	1.51e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	3.31e-06	1.5e-05	CbGpPWpGaD
Ketoconazole—CYP2B6—Metabolism—EP300—urinary bladder cancer	3.27e-06	1.48e-05	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—TYMS—urinary bladder cancer	3.21e-06	1.45e-05	CbGpPWpGaD
Ketoconazole—CYP3A5—Metabolism—EP300—urinary bladder cancer	3.2e-06	1.45e-05	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	3.17e-06	1.44e-05	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	3.17e-06	1.44e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism—PTEN—urinary bladder cancer	3.17e-06	1.44e-05	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—GPX1—urinary bladder cancer	3.04e-06	1.38e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism—EP300—urinary bladder cancer	3.02e-06	1.37e-05	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	2.98e-06	1.35e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	2.97e-06	1.35e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—PPARG—urinary bladder cancer	2.94e-06	1.34e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism—PTEN—urinary bladder cancer	2.9e-06	1.32e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Metabolism—PTGS2—urinary bladder cancer	2.9e-06	1.32e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	2.83e-06	1.28e-05	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	2.8e-06	1.27e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism—EP300—urinary bladder cancer	2.77e-06	1.26e-05	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	2.73e-06	1.24e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	2.71e-06	1.23e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism—PTEN—urinary bladder cancer	2.59e-06	1.18e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Metabolism—PTEN—urinary bladder cancer	2.53e-06	1.15e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism—EP300—urinary bladder cancer	2.47e-06	1.12e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Metabolism—EP300—urinary bladder cancer	2.41e-06	1.09e-05	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—PTEN—urinary bladder cancer	2.38e-06	1.08e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—PTEN—urinary bladder cancer	2.36e-06	1.07e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	2.32e-06	1.05e-05	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—EP300—urinary bladder cancer	2.27e-06	1.03e-05	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—PPARG—urinary bladder cancer	2.27e-06	1.03e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—EP300—urinary bladder cancer	2.25e-06	1.02e-05	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	2.18e-06	9.9e-06	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—PTEN—urinary bladder cancer	2.02e-06	9.16e-06	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—EP300—urinary bladder cancer	1.93e-06	8.73e-06	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.79e-06	8.11e-06	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—PTEN—urinary bladder cancer	1.56e-06	7.07e-06	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—EP300—urinary bladder cancer	1.49e-06	6.74e-06	CbGpPWpGaD
